Thermo Fisher Scientific (TMO) Return on Capital Employed (2009 - 2026)

Thermo Fisher Scientific has disclosed Return on Capital Employed across 18 years of filings, most recently posting 8.12% for Q1 2026.

• Quarterly Return on Capital Employed fell 57.0% year-over-year to 8.12% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.12% (down 57.0% YoY) and the FY2025 annual result came in at 8.74%, up 8.0% from the prior year.
• Return on Capital Employed retreated to 8.12% in Q1 2026, from 8.47% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 11.97% in Q2 2022 and troughed at 8.12% in Q1 2026.
• A 5-year average of 9.21% and a median of 8.58% in 2024 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 593 bps — and 2025, when it jumped 41 bps.
• Tracing TMO's Return on Capital Employed over 5 years: stood at 10.92% in 2022, then decreased by 25 bps to 8.18% in 2023, then rose by 5 bps to 8.58% in 2024, then decreased by 1 bps to 8.47% in 2025, then retreated by 4 bps to 8.12% in 2026.
• Business Quant data shows TMO's Return on Capital Employed at 8.12% in Q1 2026, 8.47% in Q4 2025, and 8.61% in Q3 2025.